Project Details
Abstract
Neutrophils play a pivotal role in the defense of the human body against infections.
However, overwhelming activation of neutrophils is known to elicit tissue damage. Human
neutrophils are known to play important roles in the pathogenesis of various diseases such as
ischemic heart disease, acute myocardial infarction, sepsis, chronic obstructive pulmonary
disease, and asthma. In response to diverse stimuli, activated neutrophils secrete a series of
cytotoxins, such as the superoxide anion, granule proteases, and bioactive lipids. Suppression
of the extensive or inappropriate activation of neutrophils using drugs has been proposed as a
way to ameliorate these inflammatory diseases. Despite this, there are only a few currently
available agents that directly modulate neutrophil proinflammatory responses in clinical
practice. Therefore, the research and development of new generation anti-inflammatory drugs
continue as important targets. Angelica genus (Umbelliferae) has traditionally been used as
the medicine and health food considered alleviating several disorders. Angelica plants exhibit
diverse ranges of pharmacological effects, such as antimicrobial activity, anti-platelet
aggregation, antioxidant, and anti-inflammatory effects. Angelica hirsutiflora is an endemic
species and a folk medicine in Taiwan. This plant is traditional used to treat inflammatory
diseases. However, the anti-inflammatory effects and active ingredients of Angelica
hirsutiflora in human neutrophils are still unknown. In searching for suitable new
anti-inflammatory agents from natural sources, a cellular model in isolated human neutrophils
will be established to elucidate the anti-inflammatory functions of Angelica hirsutiflora in
this project. In the meantime, we will explore the novel mechanism of the potential
candidates and evaluate their potentials as the lead compounds for the drug development in
this field. In the preliminary experiments, three active coumarins, osthol, auraptenol, and
imperatorin, from Angelica hirsutiflora showed potent and specific inhibition of superoxide
anion generation in formyl-L-methionyl-L-leucyl-L-phenylalanine-activated human
neutrophils with IC50 values of 7.81±2.47 nM, 0.48±0.09 μM, and 0.17±0.02 μM,
respectively. These inhibitory effects were not due to cytotoxicity because culturing with
these compounds did not cause lactate dehydrogenase release. Moreover, osthol and
imperatorin displayed no superoxide-scavenging ability, and they failed to alter subcellular
NADPH oxidase activity. Significantly, our preliminary results suggest that osthol and
imperatorin are cAMP-elevating agents in human neutrophils. Certainly, the mechanisms of
action of these compounds will be further investigated in this project. On the basis of these
preliminary findings, we therefore propose a three-year project to conduct studies in the
following aspects: (i) to examine the pharmacological effects of osthol, auraptenol, and
imperatorin on respiratory burst, degranulation, and migration in human neutrophils; (ii) to
investigate the respective roles of cAMP, cGMP, calcium, PI3K, and MAPK signal
transduction pathways in mediating the effects of osthol, auraptenol, and imperatorin. These
studies will provide new insight into the pharmacological functions of these three coumurins,
and support the hypothesis that osthol, auraptenol, and imperatorin may have the potential to
protect against the progression of inflammatory diseases. Also, our results will support the
beneficial use of this plant by traditional medicine.
Project IDs
Project ID:PC9907-0083
External Project ID:NSC99-2320-B182-006-MY3
External Project ID:NSC99-2320-B182-006-MY3
Status | Finished |
---|---|
Effective start/end date | 01/08/10 → 31/07/11 |
Keywords
- Neutrophils
- superoxide anion
- Angelica genus
- imperatonin
- cAMP
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.